Company intelligence / Profile preview

Cardiocity

Cambridge, England, United Kingdomcardiocity.com ↗

Ownership: Private
Employees: ~10
Development stage: Commercial

Overview

Cardiocity develops and markets medical-grade wearable devices and digital platforms for remote heart rhythm analysis. Their solutions are used in clinical settings to detect arrhythmias such as atrial fibrillation and support early diagnosis of cardiovascular conditions. The company’s products are CE-marked and have been adopted by healthcare providers in the UK.

Therapeutic areas: Cardiovascular
Modalities: DeviceDigital health platformRemote monitoring technology
Industry: Physiological Monitoring

Partnerships

NHS trusts in the UKpartnerships with clinics/hospitals for deployment of their devices

Beyond the preview

Go deeper on Cardiocity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cardiocity.

Explore the full profile